TriSalus Life Sciences, Inc. Fair Value, Assets, Level 2 to Level 1 Transfers, Amount
TriSalus Life Sciences, Inc. (TLSI) had Fair Value, Assets, Level 2 to Level 1 Transfers, Amount of $0 as of 2021-09-30, per its 10-Q/A filed 2021-12-13.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount · last filed 2021-12-13
- 2021-09-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-06-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-03-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2021-09-30 | $0.00 10-Q/A · filed 2021-12-13 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 |
| 2021-03-31 | $0.00 10-Q · filed 2021-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |